Research and Development
AstraZeneca shares results from ZENITH-CKD phase 2b trial for chronic kidney disease and proteinuria treatment
November 6, 2023 Research and Development AstraZeneca, CKD, Nephrology, kidney disease, proteinuria
AstraZeneca and Cellectis to collaborate for cell therapy and genomic medicine development
November 1, 2023 Research and Development AstraZeneca, CGT, Pharmacy, cell therapy, cellectis, genomic medicine
First patient enrolled in Boan Biotech’s phase 3 trial for Nivolumab in China
October 30, 2023 Research and Development Boan Biotech, China, Oncology, clinical trial, nivolumab
China’s NMPA approves ViiV Healthcare’s Vocabria in combination with Rekambys for HIV treatment
October 26, 2023 Research and Development HIV, HIV/AIDS, NMPA, ViiV Healthcare, Vocabria
Eisai shares new data for Leqembi for Alzheimer’s treatment
October 26, 2023 Research and Development Alzheimer's, Biogen, Eisai, Neurology, lecanemab
GSK shares new data for RSV vaccine Arexvy
October 25, 2023 Research and Development Arexvy, GSK, Immunology, RSV, Vaccine
AstraZeneca and Daiichi Sankyo’s Enhertu approved in EU for treatment of HER2-mutant NSCLC
October 23, 2023 Research and Development AstraZeneca, Daiichi Sankyo, Enhertu, NSCLC, Oncology
Genentech shares data from phase 3 trials of Vabysmo for retinal vein occlusion treatment
October 10, 2023 Research and Development Genentech, Opthalmology, Vabysmo, phase 3 trial, retinal vein occlusion
First patient dosed in Transgene and BioInvent’s phase 1 trial
October 10, 2023 Research and Development BioInvent, Oncology, Transgene, oncology, phase 1 trial
Sanofi shares new data for long-term efficacy of Nexviazyme for Pompe disease treatment
October 6, 2023 Research and Development Nexviazyme, Pharmacy, Pompe disease, Sanofi
Moderna shares data from phase 1/2 trial for combination flu and COVID-19 vaccine
October 5, 2023 Research and Development COVID-19, Immunology, Moderna, clinical trial, influenza, vaccines
Acurx Pharmaceuticals announces positive data from phase 2b trial for C. difficile infection treatment
October 3, 2023 Research and Development Acurx Pharmaceuticals, C. difficile, Infections and infestations, clinical trial, infection
FDA grants marketing authorisation to DNA test for predisposition to certain cancers
October 2, 2023 Research and Development FDA, Invitae, Oncology, cancer testing, oncology
BactiVac funds development of bacterial vaccines to prevent infections against antimicrobial resistance
September 28, 2023 Research and Development AMR, BactiVac, Immunology, vaccines
NMD Pharma begins phase 2 trial for spinal muscular atrophy treatment
September 27, 2023 Research and Development Musculo-skeletal disorder, NMD Pharma, clinical trial, spinal muscular atrophy
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
Dermatology leader Doncker is new Onicor CEO
